FDA Approves Lilly’s Zyprexa For Two Adolescent Indications

The U.S. Food and Drug Administration (FDA) approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old…

read the full article

If you enjoyed this post, make sure you subscribe to my RSS feed!
This entry was posted in Bipolar Disorder and tagged Bipolar Disorder And Schizophrenia, manic depression. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>